I was wondering why the remeOS sales figures weren’t reported as numbers in the latest earnings release, even though they have always been reported numerically before. This somehow supports the idea that they want to present things in as negative a light as possible. Furthermore, how on earth could the original growth guidance have gone so far off the rails, given the level of CVs involved here?
Alternatively, the numbers look so bad that they are just trying not to scare existing investors too much into cashing out in a panic. Go figure, it’s all just speculation.
For future reference below:
wb_kaavio_2022.pdf (97.7 KB)
